Adhesive small bowel obstruction (ASBO) is one of the most frequently encountered disorders in Emergency Surgery Departments worldwide without negligible hospital admission rates and social costs (1,2). Notwithstanding significant improvements in techniques and materials, intra-abdominal adhesions following abdominal surgery still represent a major unsolved and debated issue harbouring challenges regarding diagnosis, pathogenesis, management and prevention. In this setting, the cornerstone lies on a proper nosological classification with a subsequent diagnostic dilemma in distinguishing ASBO from other causes of obstruction and in an early identification of emergency surgery cases. Moreover, conflicting results raise more questions. As known, fibrous bands occur in up to 93% of patients undergoing abdominal procedures with a considerable rate of future complications, resulting in morbidity, mortality and a 30% re-admission rate at 4 years after surgery (3,4). For these reasons, recent studies and systematic reviews have pointed out the "prevention" by considering the socioeconomic burden of adhesiolyses (5-7). But, where are we standing now? Should we reconsider our mind? Do minimally invasive surgery or pharmacological barriers really reduce ASBO incidence? Does ASBO relate to the age and chronicity of diseases? Are we witnessing an epidemiological change? In reality, we are still relegated to uncertainty and to conflicting experiences, despite the presence of established diagnostic pathways and guidelines. Nowadays, it is essential to contextualise bowel obstructive syndromes to the increase of the general population's average age and its related co-morbidities. For these reasons, an invasive treatment should be quick, minimally invasive and rather decisive. But, is less better? Nakamura et al (8), in a retrospective study involving 123 ASBO patients and comparing open to laparoscopic approach, reported that open surgery was the only independent risk factor for the recurrence of small bowel obstruction (odds ratio [OR]: 5.621; P = 0.015) at multivariate analysis. Similarly, Aquina et al (9), investigating the effects of a minimally invasive strategy for colorectal resections in adhesions formation, confirmed that laparotomy was associated with a higher risk of both SBO (hazard ratio [HR]: 1.14, 95% CI: 1.03-1.26) and operation for ASBO (HR: 1.12, 95% CI: 0.94-1.32). This effect was even greater when characterizing laparoscopic-to-open conversions as an open approach (SBO: HR 1.34, 95% CI: 1.20-1.49; SBO operation: HR 1.35, 95% CI: 1.12-1.63). If on the one hand, a general trend towards minimally invasive approaches appears clear, the same can be also asserted about measures of prevention such as pharmacological agents and anti-adhesive barriers (7). Encouraging results were published on the POPA study (6) and on the ADEPT trial (10) concerning the intraperitoneal injection of icodextrin 4% during surgery with a significant reduction both in early and morbidity rates with a proven pharmacological safety, confirming the evidences of a wider Cochrane Systematic Review (11). So, why do intestinal occlusions still remain a tedious open problem? What justifies the increasing rates of relapse? In our opinion, causes are to be found in several factors. First of all, we have to face with usability and technology diffusion issues. These aspects, intimately linked to social and healthcare costs, make such strategies inaccessible to most of patients, especially in developing countries. However, subordinating health to expenditures
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